日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resveratrol-Based Liposomes Improve Cardiac Remodeling Induced by Isoproterenol Partially by Modulating MEF2, Cytochrome C and S100A1 Expression

白藜芦醇类脂质体通过调节 MEF2、细胞色素 C 和 S100A1 表达部分改善异丙肾上腺素诱导的心脏重塑

Ahlam M Alhusaini, Hanan K Alghibiwi, Wedad S Sarawi, Juman S Alsaab, Samiyah M Alshehri, Qamraa H Alqahtani, Aliah R Alshanwani, Ebtesam A Aljassas, Ebtesam N Alsultan, Iman H Hasan

Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson's Rats: Preventing Mitochondrial, Motor and Histopathological Defects

天然腺苷酸环化酶/cAMP/CREB 信号激活剂福斯高林对纹状体内 6-OHDA 损伤帕金森大鼠的作用:预防线粒体、运动和组织病理学缺陷

Metab Alharbi, Abdulrahman Alshammari, Gurpreet Kaur, Sanjeev Kalra, Sidharth Mehan, Manisha Suri, Swesha Chhabra, Nitish Kumar, Wael A Alanazi, Aliah R Alshanwani, Abdullah Hamed Al-Ghamdi, Acharan S Narula, Reni Kalfin

PUNISHER rs12318065 C>A transversion: a putative somatic driver mutation for poor prognosis in colon cancer

PUNISHER rs12318065 C>A 颠换:结肠癌预后不良的假定体细胞驱动突变

Sameerah Shaheen, Eida M Alshammari, Sara H Mokhtar, Aliah R Alshanwani, Eman A Toraih, Afaf T Ibrahiem, Manal S Fawzy, Shymaa Ahmed Maher

Chitosan nanoparticles as a promising candidate for liver injury induced by 2-nitropropane: Implications of P53, iNOS, VEGF, PCNA, and CD68 pathways.

壳聚糖纳米颗粒作为治疗 2-硝基丙烷诱导的肝损伤的一种有希望的候选药物:P53、iNOS、VEGF、PCNA 和 CD68 通路的影响

Shaheen Sameerah, Arafah Maha M, Alshanwani Aliah R, Fadda Laila Mohammed, Alhusaini Ahlam M, Ali Hanaa M, Hasan Iman H, Hagar Hanan, Alharbi Fatima Mb, AlHarthii Alaa

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function

2型糖尿病患者大隐静脉平滑肌细胞中miR-143/5表达水平升高,导致表型和功能发生持续性改变。

Riches, Kirsten; Alshanwani, Aliah R; Warburton, Philip; O'Regan, David J; Ball, Stephen G; Wood, Ian C; Turner, Neil A; Porter, Karen E